SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-024018
Filing Date
2022-06-24
Accepted
2022-06-24 16:36:44
Documents
2
Period of Report
2022-06-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1569
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4605
  Complete submission text file 0000899243-22-024018.txt   7601
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Adagio Therapeutics, Inc. (Issuer) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O POPULATION HEALTH PARTNERS, L.P. 1200 MORRIS TURNPIKE, SUITE 3005 SHORT HILLS NJ 07078
Business Address
Berry Tamsin (Reporting) CIK: 0001924202 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40703 | Film No.: 221040598